Literature DB >> 27406097

Prognostic Impact of Port-Site Metastasis After Diagnostic Laparoscopy for Epithelial Ovarian Cancer.

Beyhan Ataseven1, Christoph Grimm2,3, Philipp Harter2, Sebastian Heikaus4, Florian Heitz2, Alexander Traut2, Sonia Prader2, Annett Kahl2, Stefanie Schneider2, Christian Kurzeder2, Andreas du Bois2.   

Abstract

BACKGROUND: This study was designed to evaluate the prevalence, morbidity, and prognostic impact of port-site metastasis (PSM) in patients with epithelial ovarian cancer (EOC) undergoing laparoscopy before subsequent primary debulking surgery (PDS).
METHODS: All consecutive patients treated between 2000 and 2014, who had a laparoscopy followed by PDS, were extracted from our prospectively maintained database. All patients with histological examination of port-sites were included in this unicentric exploratory analysis.
RESULTS: A total of 250 (25.5 %) of 982 patients with EOC underwent laparoscopy before PDS. Port-site resection was performed in those 214 (85.6 %) patients in whom a complete or almost complete resection with residuals ≤1 cm was achieved. Median interval between laparoscopy and PDS was 25 days. PSM was detected in 100 of 214 patients (46.7 %). Risk factors for PSM were higher tumor stage (odds ratio [OR] 13.5, 95 % confidence interval [CI] 2.9-62.0, p = 0.04), positive lymph node status (OR 3.0, 95 % CI 1.3-6.7, p = 0.009), and ascites >500 mL (OR 3.9, 95 % CI 1.5-10.0, p = 0.005). Wound healing disorders and postoperative morbidity were significantly higher in patients with PSM (Clavien-Dindo Classification grade 3-5: 41.0 vs. 14.9 %, p < 0.001). However, multivariate Cox-regression models did not identify PSM as independent prognostic factor.
CONCLUSIONS: The prevalence of PSM after laparoscopy in EOC patients is considerably high. PSM had no impact on survival; however, PSM were associated with more postoperative complications and a higher surgical treatment burden. This should be balanced with the expected benefit when laparoscopy is considered for the management of EOC.

Entities:  

Mesh:

Year:  2016        PMID: 27406097     DOI: 10.1245/s10434-016-5415-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Incidence of and risk factors associated with lung metastases in newly diagnosed epithelial ovarian cancer with a look on prognosis after diagnosis: a population-based cohort study of the SEER database.

Authors:  Jiaqin Xu; Iftikhar Hussain; Liuying Wang; Kui Deng; Liang Zhao; Keqiang Zhou; Liuchao Zhang; Zhengyi Xu; Kang Li
Journal:  Arch Gynecol Obstet       Date:  2021-02-26       Impact factor: 2.344

2.  Undifferentiated Carcinoma After Laparoscopic Surgery for a Cystic Ovarian Tumour: A Case Study.

Authors:  Kosuke Shigematsu; Koki Samejima; Keisuke Sawada; Takahiro Uotani; Taichi Akahori; Shigetaka Matsunaga; Tomonori Nagai; Jun-Ichi Tamaru; Yasushi Takai
Journal:  Cancer Diagn Progn       Date:  2021-11-03

3.  RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery.

Authors:  A Fagotti; G Vizzielli; M Petrillo; G Scambia
Journal:  Gynecol Oncol Rep       Date:  2016-11-10

4.  Response to the letter of Fagotti et al. regarding the manuscript: "Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery".

Authors:  Florian Heitz; Philipp Harter; Beyhan Ataseven; Andreas du Bois
Journal:  Gynecol Oncol Rep       Date:  2016-11-11

5.  Port site recurrence and unusual diffuse subcutaneous metastases of unexpected early stage ovarian cancer after laparoscopic surgery: a case report.

Authors:  Atsushi Fusegi; Noriko Oshima; Takashi Nakasuji; Tomonori Ishikawa; Kimio Wakana; Naoyuki Yoshiki; Naoyuki Miyasaka
Journal:  J Rural Med       Date:  2019-05-30

6.  Role of diagnostic laparoscopy in patients with large cell neuroendocrine carcinoma of the ovary with cancerous peritonitis: case report and review of the literature.

Authors:  Hideaki Tsuyoshi; Kenji Yashiro; Shizuka Yamada; Makoto Yamamoto; Toshimichi Onuma; Tetsuji Kurokawa; Yoshio Yoshida
Journal:  J Ovarian Res       Date:  2019-10-15       Impact factor: 4.234

7.  miR-548e Sponged by ZFAS1 Regulates Metastasis and Cisplatin Resistance of OC by Targeting CXCR4 and let-7a/BCL-XL/S Signaling Axis.

Authors:  Jing Zhang; Li-Ni Quan; Qiu Meng; Hai-Yan Wang; Jie Wang; Pin Yu; Jian-Tao Fu; Ying-Jia Li; Jin Chen; Hong Cheng; Qing-Ping Wu; Xin-Rong Yu; Hong-Ye Yun; Shou-Guo Huang
Journal:  Mol Ther Nucleic Acids       Date:  2020-04-07       Impact factor: 8.886

8.  The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer.

Authors:  Björg Jónsdóttir; Marta Lomnytska; Inger Sundström Poromaa; Ilvars Silins; Karin Stålberg
Journal:  Ann Surg Oncol       Date:  2020-05-29       Impact factor: 5.344

Review 9.  Comparison of the survival outcomes of laparoscopy versus laparotomy in treatment of early-stage ovarian cancer: a systematic review and meta-analysis.

Authors:  Qingduo Kong; Hongyi Wei; Jing Zhang; Yilin Li; Yongjun Wang
Journal:  J Ovarian Res       Date:  2021-03-16       Impact factor: 4.234

10.  Bimodal magnetic resonance and optical imaging of extracellular matrix remodelling by orthotopic ovarian tumours.

Authors:  Filip Bochner; Liat Fellus-Alyagor; Dafna Ketter; Ofra Golani; Inbal Biton; Michal Neeman
Journal:  Br J Cancer       Date:  2020-05-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.